AN Ventures

Funding rounds backed by AN Ventures.

Export CSV
Funding disclosed in full
$99.5M
Median round
$99.5M
Rounds in calculation
1
Funding rounds with company descriptions, amounts, stages and announcement dates
CompanyRoundMarketInvestorsAnnouncedDetails
City Therapeutics

Develops next-generation RNAi therapeutics and engineering platform for multiple disease areas

$99.5MSeries BBiotechUnited States
11 participantsAN VenturesARCH Venture PartnersCasdin CapitalFidelity Management & Research CompanyInvusNYBC VenturesRegeneron VenturesRock Springs CapitalSlate Path CapitalSofinnova InvestmentsViking Global Investors